Search
Close this search box.
Register
Healthed-White-on-Blue
Search
Close this search box.

Understanding long COVID

Prof Andrew Lloyd

Speaker

Prof Andrew Lloyd

Infectious Diseases Physician, Prince of Wales Hospital, Sydney; Academic Researcher, Kirby Institute, University of NSW

More from this speaker

CPD outcomes

Educational Activities (EA)

1-3 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

1-3 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

1-3 hours

These are activities that use your work data to ensure quality results.

Description

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone

Prof Andrew Sindone

Heart Failure – Demystifying Pharmacological Management for GPs

Dr Rupert Hinds

Dr Rupert Hinds

Iron Deficiency in Children & Young People

Speaker TBA

Speaker TBA

Heart Failure – Assessment and Monitoring in Primary Care

Prof Dave Singh

Prof Dave Singh

COPD Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

14 May 2024
Register Now

Recent videos

Fezolinetant for vasomotor symptoms associated with menopause

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

Share this

Date published: 7 February 2024

Next up

Browse the latest videos from Healthed.

View more
Drugs and devices, Sexual health, Women's health

Fezolinetant for vasomotor symptoms associated with menopause

In this Product Explainer, Obstetrician and Gynaecologist Prof Rod Baber explains the role of fezolinetant for the treatment of vasomotor symptoms associated with menopause...
Drugs and devices, Geriatric medicine, Infectious diseases, Vaccination

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform